Fabrice Carrat

Summary

Country: France

Publications

  1. ncbi Effect of oseltamivir, zanamivir or oseltamivir-zanamivir combination treatments on transmission of influenza in households
    Fabrice Carrat
    APHP, Hopital Saint Antoine, Unité de santé publique, Paris, France
    Antivir Ther 17:1085-90. 2012
  2. ncbi Risk perception and priority setting for intervention among hepatitis C virus and environmental risks: a cross-sectional survey in the Cairo community
    Michael Schwarzinger
    INSERM UMR_S 707, and UPMC, Univ Paris 06, F 75012 Paris, France
    BMC Public Health 10:773. 2010
  3. ncbi Repeated influenza vaccination of healthy children and adults: borrow now, pay later?
    F Carrat
    Epidemiology and Information Sciences, U707, Institut National de la Sante et de la Recherche Medicale, Paris, France
    Epidemiol Infect 134:63-70. 2006
  4. ncbi Influenza vaccine: the challenge of antigenic drift
    F Carrat
    Universite Pierre et Marie Curie, Paris 6, UMR S 707, Paris, France INSERM, UMR S 707, Paris, France
    Vaccine 25:6852-62. 2007
  5. ncbi General practitioners' management of influenza with or without neuraminidase inhibitors
    Fabrice Carrat
    INSERM U 707, , Paris, France
    Eur J Gen Pract 13:157-9. 2007
  6. ncbi A 'small-world-like' model for comparing interventions aimed at preventing and controlling influenza pandemics
    Fabrice Carrat
    Universite Pierre et Marie Curie PARIS6, INSERM, UMR S 707, Paris F 75012, France
    BMC Med 4:26. 2006
  7. ncbi Time lines of infection and disease in human influenza: a review of volunteer challenge studies
    Fabrice Carrat
    Universite Pierre et Marie Curie PARIS6, UMR S 707, Paris, France
    Am J Epidemiol 167:775-85. 2008
  8. ncbi A virologic survey of patients admitted to a critical care unit for acute cardiorespiratory failure
    Fabrice Carrat
    Groupe Hospitalier Universitaire Est et Ouest, Assistance Publique Hopitaux de Paris, Paris, France
    Intensive Care Med 32:156-9. 2006
  9. ncbi Serum alpha-fetoprotein predicts virologic response to hepatitis C treatment in HIV coinfected patients
    Fabrice Carrat
    UPMC Paris6, UMR S707, INSERM, UMR S707, Saint Antoine Hospital, Assistance Publique Hopitaux de Paris, France
    AIDS 22:1513-5. 2008
  10. ncbi Insulin resistance impairs sustained virological response rate to pegylated interferon plus ribavirin in HIV-hepatitis C virus-coinfected patients: HOMAVIC-ANRS HC02 Study
    Patrice Cacoub
    Universite Pierre et Marie Curie Paris 6, CNRS, UMR 7087, Paris, France
    Antivir Ther 14:839-45. 2009

Detail Information

Publications81

  1. ncbi Effect of oseltamivir, zanamivir or oseltamivir-zanamivir combination treatments on transmission of influenza in households
    Fabrice Carrat
    APHP, Hopital Saint Antoine, Unité de santé publique, Paris, France
    Antivir Ther 17:1085-90. 2012
    ..The effectiveness of neuraminidase inhibitors to reduce transmission when used as treatment in influenza-infected patients remains debated...
  2. ncbi Risk perception and priority setting for intervention among hepatitis C virus and environmental risks: a cross-sectional survey in the Cairo community
    Michael Schwarzinger
    INSERM UMR_S 707, and UPMC, Univ Paris 06, F 75012 Paris, France
    BMC Public Health 10:773. 2010
    ..However, dramatic healthcare budget constraints limit access to the costly treatment. We assessed risk perception and priority setting for intervention among HCV, unsafe water, and outdoor air pollution in Cairo city...
  3. ncbi Repeated influenza vaccination of healthy children and adults: borrow now, pay later?
    F Carrat
    Epidemiology and Information Sciences, U707, Institut National de la Sante et de la Recherche Medicale, Paris, France
    Epidemiol Infect 134:63-70. 2006
    ..2 (vaccination after 50 years) to 2.4 (vaccination from birth). These findings have important implications for influenza vaccination policies...
  4. ncbi Influenza vaccine: the challenge of antigenic drift
    F Carrat
    Universite Pierre et Marie Curie, Paris 6, UMR S 707, Paris, France INSERM, UMR S 707, Paris, France
    Vaccine 25:6852-62. 2007
    ..In addition to the use of vaccine adjuvants, emerging research areas include development of a universal vaccine and the use of vaccines that exploit mechanisms of cross-protective immunity...
  5. ncbi General practitioners' management of influenza with or without neuraminidase inhibitors
    Fabrice Carrat
    INSERM U 707, , Paris, France
    Eur J Gen Pract 13:157-9. 2007
  6. ncbi A 'small-world-like' model for comparing interventions aimed at preventing and controlling influenza pandemics
    Fabrice Carrat
    Universite Pierre et Marie Curie PARIS6, INSERM, UMR S 707, Paris F 75012, France
    BMC Med 4:26. 2006
    ..With an influenza pandemic seemingly imminent, we constructed a model simulating the spread of influenza within the community, in order to test the impact of various interventions...
  7. ncbi Time lines of infection and disease in human influenza: a review of volunteer challenge studies
    Fabrice Carrat
    Universite Pierre et Marie Curie PARIS6, UMR S 707, Paris, France
    Am J Epidemiol 167:775-85. 2008
    ....
  8. ncbi A virologic survey of patients admitted to a critical care unit for acute cardiorespiratory failure
    Fabrice Carrat
    Groupe Hospitalier Universitaire Est et Ouest, Assistance Publique Hopitaux de Paris, Paris, France
    Intensive Care Med 32:156-9. 2006
    ..To document the prevalence of respiratory virus infections in patients with chronic cardiac or pulmonary disorders admitted to a critical care unit for acute cardiorespiratory failure...
  9. ncbi Serum alpha-fetoprotein predicts virologic response to hepatitis C treatment in HIV coinfected patients
    Fabrice Carrat
    UPMC Paris6, UMR S707, INSERM, UMR S707, Saint Antoine Hospital, Assistance Publique Hopitaux de Paris, France
    AIDS 22:1513-5. 2008
    ..83; 95% confidence interval 1.05-3.20). Serum alpha-fetoprotein measurement should be integrated in the pretreatment assessment of prognostic factors of a virologic response...
  10. ncbi Insulin resistance impairs sustained virological response rate to pegylated interferon plus ribavirin in HIV-hepatitis C virus-coinfected patients: HOMAVIC-ANRS HC02 Study
    Patrice Cacoub
    Universite Pierre et Marie Curie Paris 6, CNRS, UMR 7087, Paris, France
    Antivir Ther 14:839-45. 2009
    ..The aim of this study was to assess the effect of insulin resistance (IR) on the response to hepatitis C virus (HCV) therapy in HIV-HCV-coinfected patients...
  11. ncbi Spontaneous hepatic decompensation in patients coinfected with HIV and hepatitis C virus during interferon-ribavirin combination treatment
    Firouzé Bani-Sadr
    INSERM U707, Faculte de Medecine Hopital Saint Antoine, Paris, France
    Clin Infect Dis 41:1806-9. 2005
    ..02), and elevated total bilirubin level (OR, 7.9; 95% CI, 1.08-93.3; P<.03). Didanosine should thus not be given to patients with cirrhosis, particularly when treatments for HCV and HIV infections have to be administered concomitantly...
  12. ncbi Hepatic steatosis in HIV-HCV coinfected patients: analysis of risk factors
    Firouzé Bani-Sadr
    Groupe Hospitalier Universitaire Est, Universite Paris 6, INSERM V707, Paris, France
    AIDS 20:525-31. 2006
    ..To evaluate the prevalence and severity of steatosis and possible interactions between steatosis, host factors, viral factors, and treatment for HIV infection in HIV-hepatitis C virus (HCV) coinfected patients...
  13. ncbi Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis
    Benjamin Terrier
    Department of Internal Medicine, Universite Pierre et Marie Curie, Paris, France
    J Hepatol 55:756-61. 2011
    ..Data are lacking in HIV-HCV coinfected patients...
  14. ncbi High hepatitis C virus viral load in HIV/hepatitis C virus-co-infected patients: a different influence of protease inhibitor and non-protease inhibitor-based HAART?
    Firouzé Bani-Sadr
    Groupe Hospitalier Universitaire Est, Universite Paris 6, INSERM U707, Paris, France
    AIDS 21:1645-8. 2007
    ..Antiretroviral therapy in general was independently associated with lower HCV viral load. This suggests that HCV viral load kinetics could differ according to the choice of HAART regimen...
  15. ncbi Online detection and quantification of epidemics
    Camille Pelat
    Universite Pierre et Marie Curie Paris 6, UMR S 707, Paris, 75012 France
    BMC Med Inform Decis Mak 7:29. 2007
    ..However, implementation of the method may be difficult due to lack of statistical expertise. No dedicated tool is available to perform and guide analyses...
  16. ncbi Prediction of the spread of influenza epidemics by the method of analogues
    Cecile Viboud
    Epidemiology and Information Sciences, INSERM Unit 444, Universite Pierre et Marie Curie, Paris, France
    Am J Epidemiol 158:996-1006. 2003
    ..001). Similar results were obtained for national incidence forecasts. From the results of this method, maps of influenza epidemic forecasts can be made in countries in which national and regional data are available...
  17. ncbi How to measure the diagnostic accuracy of noninvasive liver fibrosis indices: the area under the ROC curve revisited
    Jerome Lambert
    Université Pierre et Marie Curie Paris INSERM, UMR S 707 unité de santé publique, Assistance Publique Hopitaux de Paris, Hopital Saint Antoine, Paris, France
    Clin Chem 54:1372-8. 2008
    ..We explored other fibrosis staging accuracy measures designed for ordinal gold standards, the C-statistic and the Obuchowski measure...
  18. ncbi Field effectiveness of pandemic and 2009-2010 seasonal vaccines against 2009-2010 A(H1N1) influenza: estimations from surveillance data in France
    Camille Pelat
    UPMC Universite Paris 06, Umrs 707, Paris, France
    PLoS ONE 6:e19621. 2011
    ..We also compare vaccine effectiveness against ILI versus laboratory-confirmed pandemic A(H1N1) influenza, and assess the possible bias caused by using non-specific endpoints and observational data...
  19. ncbi Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis
    Christophe Corpechot
    Service d Hepatologie, Centre de Référence des Maladies Inflammatoires des Voies Biliaires, Hopital Saint Antoine, Assistance Publique Hopitaux de Paris APHP, Paris, France
    Hepatology 56:198-208. 2012
    ..Over a 5-year period, on-treatment liver stiffness appears stable in most noncirrhotic PBC patients, whereas it significantly increases in patients with cirrhosis. Progression of liver stiffness in PBC is predictive of poor outcome...
  20. ncbi Nationwide surveillance of 18 respiratory viruses in patients with influenza-like illnesses: a pilot feasibility study in the French Sentinel Network
    Alessandra Falchi
    INSERM, UMR S 707, Paris, France
    J Med Virol 83:1451-7. 2011
    ..Although feasibility has not been demonstrated yet, it will be evaluated over the winter of 2010-2011...
  21. ncbi Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial
    Fabrice Carrat
    Groupe Hospitalier Universitaire Est, , INSERM U444, Paris, France
    JAMA 292:2839-48. 2004
    ..CONCLUSION: In combination with ribavirin, treatment with peginterferon alfa-2b is more effective than standard interferon alfa-2b for HCV infection in HIV-infected patients...
  22. ncbi Influenza epidemics in the United States, France, and Australia, 1972-1997
    Cecile Viboud
    Institut National de la Sante et de la Recherche Medicale, Paris, France
    Emerg Infect Dis 10:32-9. 2004
    ..These results support a high correlation at the hemisphere level and suggest that the global interhemispheric circulation of epidemics follows an irregular pathway with recurrent changes in the leading hemisphere...
  23. ncbi Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: the fibrovic study--ANRS HC02
    Patrice Cacoub
    Universite Pierre et Marie Curie Paris 6, CNRS, UMR 7087, Paris, France
    J Hepatol 48:765-73. 2008
    ..To compare non-invasive biological liver fibrosis scores, as alternatives to liver biopsy, in HIV/HCV co-infected patients...
  24. ncbi Risk factors of influenza transmission in households
    Cecile Viboud
    Epidemiology and Information Sciences, Universite Pierre et Marie Curie, Paris
    Br J Gen Pract 54:684-9. 2004
    ..Influenza transmission in households is a subject of renewed interest, as the vaccination of children is currently under debate and antiviral treatments have been approved for prophylactic use...
  25. ncbi Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study
    Jessica Coelho
    Department of Digestive Diseases, Lariboisiere Hospital, Paris, France
    Gut 60:198-203. 2011
    ..The aim of this study was to evaluate the pregnancy outcome of women with IBD who have been exposed to thiopurines...
  26. ncbi The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis
    Christophe Corpechot
    Hopital Saint Antoine, Service d Hepatologie, Paris, France
    Gastroenterology 128:297-303. 2005
    ..We used a multistate modeling approach to assess the effect of ursodeoxycholic acid (UDCA) therapy on the natural course of primary biliary cirrhosis (PBC), which remains controversial...
  27. ncbi Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease
    Harry Sokol
    Department of Gastroenterology, AP HP, Hôpital Saint Antoine and UPMC University of Paris, Paris, France
    Inflamm Bowel Dis 18:2063-71. 2012
    ..We assessed this risk in the CESAME French nationwide prospective observational cohort...
  28. ncbi Integrative study of pandemic A/H1N1 influenza infections: design and methods of the CoPanFlu-France cohort
    Nathanael Lapidus
    Institut National de la Sante et de la Recherche Medicale, UMR S 707, F 75012 Paris, France
    BMC Public Health 12:417. 2012
    ....
  29. ncbi Varicella in French adolescents and adults: individual risk assessment and cost-effectiveness of routine vaccination
    Thomas Hanslik
    Department of Public Health, Hopital Saint Antoine, INSERM U444, Universite Paris 6, Assistance Publique Hopitaux de Paris, Paris, France
    Vaccine 21:3614-22. 2003
    ..From the societal perspective, such screening and vaccination might save costs...
  30. ncbi Mortality burden of the 1918-1919 influenza pandemic in Europe
    Séverine Ansart
    INSERM, U 707, Paris, France
    Influenza Other Respi Viruses 3:99-106. 2009
    ..The origin and estimated death toll of the 1918-1919 epidemic are still debated. Europe, one of the candidate sites for pandemic emergence, has detailed pandemic mortality information...
  31. ncbi Usefulness of co-treatment with immunomodulators in patients with inflammatory bowel disease treated with scheduled infliximab maintenance therapy
    Harry Sokol
    Gastroenterology and Nutrition Department, Saint Antoine Hospital, AP HP, 184 rue du Faubourg Saint Antoine, Paris, France
    Gut 59:1363-8. 2010
    ..The aim of this study was to assess whether IS co-treatment is useful in patients with inflammatory bowel disease (IBD) on scheduled IFX infusions...
  32. ncbi Predicting pneumonia and influenza mortality from morbidity data
    Lise Denoeud
    Universite Pierre et Marie Curie Paris 6, UMR S 707, Paris, France
    PLoS ONE 2:e464. 2007
    ..Few European countries conduct reactive surveillance of influenza mortality, whereas most monitor morbidity...
  33. ncbi Simultaneous investigation of influenza and enteric viruses in the stools of adult patients consulting in general practice for acute diarrhea
    Christophe Arena
    INSERM, UMR S 707, 75012, Paris, France
    Virol J 9:116. 2012
    ....
  34. ncbi Risk factors for acute liver enzyme abnormalities in HIV-hepatitis B virus-coinfected patients on antiretroviral therapy
    Olivia Chauvel
    AP HP, Hopital Saint Antoine, Service de Maladies Infectieuses et Tropicales, Paris, France
    Antivir Ther 12:1115-26. 2007
    ..Little is known about the prognostic factors of acute liver enzyme variations in HIV-hepatitis B virus (HBV)-coinfected patients...
  35. ncbi Planning for the next influenza H1N1 season: a modelling study
    Fabrice Carrat
    Universite Pierre et Marie Curie Paris 6, UMR S 707, Paris, France
    BMC Infect Dis 10:301. 2010
    ..The level of herd immunity before and after the first 2009 pandemic season is not precisely known, and predicting the shape of the next pandemic H1N1 season is a difficult challenge...
  36. ncbi Comparison of elastography, serum marker scores, and histology for the assessment of liver fibrosis in hepatitis B virus (HBV)-infected patients in Burkina Faso
    Philippe Bonnard
    Maladies Infectieuses, Hopital Tenon, UPMC Univ Paris 06, UPMC Paris Liver Center, Paris, France
    Am J Trop Med Hyg 82:454-8. 2010
    ..This study shows that the results of alternative methods concord with those of histology in HBV-infected patients in Burkina Faso. These alternative techniques could help physicians to identify patients requiring treatment...
  37. ncbi Effect of influenza vaccination of nursing home staff on mortality of residents: a cluster-randomized trial
    Magali Lemaitre
    Department of Epidemiology, Information Systems, and Modeling, University Pierre and Marie Curie Paris 6, UMR S 707, Paris, France
    J Am Geriatr Soc 57:1580-6. 2009
    ..To evaluate the effect of staff influenza vaccination on all-cause mortality in nursing home residents...
  38. ncbi Age distribution of cases and deaths during the 1889 influenza pandemic
    Sophie Valtat
    Institut National de la Sante et de la Recherche Medicale, U 707, F 75012 Paris, France
    Vaccine 29:B6-B10. 2011
    ..Adding 1889 to the short catalogue of influenza pandemics previously studied makes the 1918 pandemic even more exceptional in terms of mortality burden and age distribution of deaths...
  39. ncbi Surgical mask to prevent influenza transmission in households: a cluster randomized trial
    Laetitia Canini
    UMR S 707, UPMC Paris 6, Paris, France
    PLoS ONE 5:e13998. 2010
    ..However, data on their effectiveness for limiting transmission are scarce. We evaluated the effectiveness of facemask use by index cases for limiting influenza transmission by large droplets produced during coughing in households...
  40. ncbi Long-term outcomes of pandemic 2009 influenza A(H1N1)-associated severe ARDS
    Charles Edouard Luyt
    Service de Reanimation Medicale, Groupe Hospitalier Pitie Salpetriere, Assistance Publique Hôpitaux de Paris et Université Paris 6 Pierre et Marie Curie, Paris, France
    Chest 142:583-92. 2012
    ..The objective of this study was to compare the 1-year outcomes of survivors of A(H1N1)-associated ARDS, according to use or no use of extracorporeal lung assist (ECLA), using its need as an ARDS severity surrogate...
  41. ncbi Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey
    Benjamin Terrier
    Department of Internal Medicine, Groupe Hospitalier Pitie Salpetriere, Assistance Publique des Hopitaux de Paris, Universite Pierre et Marie Curie, 47 83 boulevard de l Hopital, Paris, France
    Blood 119:5996-6004. 2012
    ..The role of each of these strategies remains to be defined in well-designed randomized controlled trials...
  42. ncbi Transmissibility and geographic spread of the 1889 influenza pandemic
    Alain Jacques Valleron
    Institut National de la Sante et de la Recherche Medicale, Paris, France
    Proc Natl Acad Sci U S A 107:8778-81. 2010
    ..Social and geographic factors probably shape the local R(0) , and they could be identified to design optimal mitigation scenarios tailored to each city...
  43. ncbi Chronic hepatitis C virus infection: does it really impact health-related quality of life? A study in rural Egypt
    Michael Schwarzinger
    INSERM U444, Faculte de Medecine Saint Antoine, Paris, France
    Hepatology 40:1434-41. 2004
    ....
  44. ncbi Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
    Laurent Beaugerie
    Department of Gastroenterology, Assistance Publique Hopitaux de Paris AP HP, Hopital Saint Antoine, Universite Pierre et Marie Curie Paris VI, Paris, France
    Lancet 374:1617-25. 2009
    ..Reports of an increased risk of lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease are controversial. We assessed this risk in a prospective observational cohort study...
  45. ncbi Antibiotic treatment for influenza does not affect resolution of illness, secondary visits or lost workdays
    Fabrice Carrat
    , INSERM Unit 444, , , Paris, France
    Eur J Epidemiol 19:703-5. 2004
    ..Antibiotics are unnecessary expenses in the initial treatment of influenza, as they can give potential side-effects and contribute to spread of antibiotic-resistant bacteria...
  46. ncbi Influenza burden of illness: estimates from a national prospective survey of household contacts in France
    Fabrice Carrat
    INSERM U444, Faculte de Medecine Saint Antoine, 27 rue Chaligny, 75571 Paris Cedex 12, France
    Arch Intern Med 162:1842-8. 2002
    ..We estimated the impact of influenza in terms of uncomplicated morbidity and its consequences on health care utilization and lost workdays...
  47. ncbi Severe weight loss in HIV / HCV-coinfected patients treated with interferon plus ribavirin: incidence and risk factors
    F Bani-Sadr
    Groupe Hospitalier Universitaire Est, Universite Paris 6, INSERM U707, Paris, France
    J Viral Hepat 15:255-60. 2008
    ..These findings show that severe weight loss is a frequent side effect of anti-HCV therapy in HIV / HCV-coinfected patients. The underlying mechanisms remain to be identified...
  48. ncbi A Bayesian MCMC approach to study transmission of influenza: application to household longitudinal data
    S Cauchemez
    INSERM U444, Paris, France
    Stat Med 23:3469-87. 2004
    ..3,5.2]) and adults (3.9 days, 95 per cent CI [3.2,4.9]). The posterior probability that children had a larger community risk was 76 per cent and the posterior probability that they were more susceptible than adults was 79 per cent...
  49. ncbi Evaluation of clinical case definitions of influenza: detailed investigation of patients during the 1995-1996 epidemic in France
    F Carrat
    Unite de Recherches, Epidémiologie et Sciences de l Information, Institute National de la Sante et de la Recherche Medicale, Paris
    Clin Infect Dis 28:283-90. 1999
    ....
  50. ncbi HIV and hepatitis C virus co-infection
    F Carrat
    Epidemiology of Infectious Diseases, INSERM U444, Paris, France
    Lancet Infect Dis 5:71. 2005
  51. ncbi Assessment and determinants of aesthetic discomfort in hand osteoarthritis
    Bridget Hodkinson
    Department of Rheumatology, Saint Antoine Hospital, AP HP, Paris, France
    Ann Rheum Dis 71:45-9. 2012
    ..Dissatisfaction with hand appearance is frequently the presenting complaint of patients with hand osteoarthritis (HOA), yet no tool exists for its measurement and few studies have examined aesthetic discomfort...
  52. ncbi Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis
    David Saadoun
    Université Pierre et Marie Curie Université Paris 06, Paris, France
    N Engl J Med 365:2067-77. 2011
    ..We reasoned that interleukin-2, a cytokine that promotes Treg survival and function, could be beneficial for patients with vasculitis that is resistant to HCV therapy...
  53. ncbi WTW--an algorithm for identifying "who transmits to whom" in outbreaks of interhuman transmitted infectious agents
    Nathanael Lapidus
    UPMC Paris 6, UMR S 707, Paris, France
    J Am Med Inform Assoc 17:348-53. 2010
    ..The use of this algorithm to draw transmission maps in investigations of outbreaks with person-to-person transmitted agents could potentially guide public health measures regarding the control of such outbreaks...
  54. ncbi Major role of hepatitis B genotypes in liver fibrosis during coinfection with HIV
    Karine Lacombe
    INSERM U707, Paris, France
    AIDS 20:419-27. 2006
    ....
  55. ncbi Primary biliary cirrhosis: incidence and predictive factors of cirrhosis development in ursodiol-treated patients
    Christophe Corpechot
    , , Paris, France
    Gastroenterology 122:652-8. 2002
    ..CONCLUSIONS: This study provides new data about the time course of PBC under UDCA and constitutes a rationale for the design and evaluation of clinical trials aimed to assess the efficacy of drugs associated with UDCA...
  56. ncbi Mortality burden of the 2009 A/H1N1 influenza pandemic in France: comparison to seasonal influenza and the A/H3N2 pandemic
    Magali Lemaitre
    Fogarty International Center, National Institutes of Health, Bethesda, Maryland, USA
    PLoS ONE 7:e45051. 2012
    ..We estimate the age- and cause-specific excess mortality impact of the pandemic in France, relative to that of other countries and past epidemic and pandemic seasons...
  57. ncbi Comparative age distribution of influenza morbidity and mortality during seasonal influenza epidemics and the 2009 H1N1 pandemic
    Magali Lemaitre
    UPMC Univ Paris 6, UMR S 707, Paris F 75012, France
    BMC Infect Dis 10:162. 2010
    ..Here we compared the age distributions of morbidity and mortality during two seasonal influenza epidemics (H1N1 and H3N2) in France and the United States with those of the 2009 H1N1 pandemic waves in the same countries...
  58. ncbi Population modeling of influenza A/H1N1 virus kinetics and symptom dynamics
    Laetitia Canini
    Epidemiologie, Systèmes d Information, Modelisation, UMR S 707, Faculte de Medecine Saint Antoine, 27 rue Chaligny, 75571 Paris, Cedex 12, France
    J Virol 85:2764-70. 2011
    ..This approach could help to optimize studies of influenza VK and SD and to predict the effect of antivirals on infectiousness and symptoms...
  59. ncbi Exploring cross-protection between influenza strains by an epidemiological model
    Audrey Lavenu
    Institut National de la Santé Et de la Recherche Médicale INSERM Unité 444, Faculte de Medecine Saint Antoine, 27 rue Chaligny, 75571 Paris Cedex 12, France
    Virus Res 103:101-5. 2004
    ..We show that a cross-protection of 50% between the two strains is sufficient to explain why we observe a single influenza illness peak in temperate countries...
  60. ncbi Monitoring epidemiologic surveillance data using hidden Markov models
    Y Le Strat
    Unité de Recherches Epidémiologie et Sciences de l Information, INSERM, U444 Institut Fédératif Saint Antoine de Recherche sur la Santé, 27, rue Chaligny, 75571 Paris, Cedex 12, France
    Stat Med 18:3463-78. 1999
    ..The results justify a wider use of this method for analysing surveillance data...
  61. ncbi Risk factors for anaemia in human immunodeficiency virus/hepatitis C virus-coinfected patients treated with interferon plus ribavirin
    F Bani-Sadr
    Groupe Hospitalier Universitaire Est, Universite Paris, INSERM U707, Paris, France
    J Viral Hepat 14:639-44. 2007
    ..26-0.49, P < 0.0001) and in patients receiving protease inhibitor-based antiretroviral therapy (OR, 0.51 95% CI, 0.30-0.86, P = 0.0114). Zidovudine discontinuation could help to avoid anaemia associated with anti-HCV therapy...
  62. ncbi Management of chronic hepatitis C in French departments of internal medicine and infectious diseases
    P Cacoub
    Department of Internal Medicine, hôpital La Pitié Salpêtrière, 83 Boulevard de l hopital, 75651, Paris, France
    Epidemiol Infect 133:305-14. 2005
    ..Nevertheless, means of increasing the availability of antiviral therapies, particularly for patients with HIV co-infection or injecting drug use, require further study...
  63. ncbi Bedside rapid flu test and zanamivir prescription in healthy working adults: a cost-benefit analysis
    Michael Schwarzinger
    Institut National de la Sante et de la Recherche Medicale, u444, Hopital Saint Antoine, Paris, France
    Pharmacoeconomics 21:215-24. 2003
    ..Zanamivir, a neuraminidase inhibitor, reduces the number of days of illness in influenza-positive patients. New bedside rapid flu tests (RFT) should increase the number of influenza-positive patients whom receive zanamivir appropriately...
  64. ncbi Diagnosis scoring for clinical identification of children with heterozygous familial hypercholesterolemia
    Pascale Benlian
    Assistance Publique Hopitaux de Paris, Hopital Saint Antoine, Reference Laboratory for the Diagnosis of Rare Diseases, Department of Molecular Biology and Biochemistry, France
    J Pediatr Gastroenterol Nutr 48:456-63. 2009
    ..In a pediatric setting, heterozygous FH (hFH) in children may not be identified from common forms of hypercholesterolemia (HC)...
  65. ncbi Persistently normal alanine aminotransferase levels in HIV/HCV-coinfected patients: the role of steatosis
    F Bani-Sadr
    Groupe Hospitalier Universitaire Est, INSERM U 707, Universite Pierre et Marie Curie, Paris, France
    HIV Med 10:417-21. 2009
    ..We analysed factors associated with persistently normal ALT levels, defined as at least three consecutive normal ALT values over a 6-month period, in a group of 381 HIV/HCV-coinfected patients...
  66. ncbi Effects of current and former cigarette smoking on the clinical course of Crohn's disease
    J Cosnes
    Service d hépatogastroentérologie et nutrition, Hopital Rothschild, Paris, France
    Aliment Pharmacol Ther 13:1403-11. 1999
    ....
  67. ncbi Air pollution and respiratory drug sales in the City of Le Havre, France, 1993-1996
    A Zeghnoun
    Unité de Biomathématiques et Biostatistiques, INSERM U 444, Paris, France
    Environ Res 81:224-30. 1999
    ..027 (95% CI 1.004-1.051) for lag 3 and RR= 1.032 (95% CI 1.009-1.056) for lag 9. Our study concludes that ambulatory respiratory drug sales data could be useful for epidemiological surveillance of air pollutant health effects...
  68. ncbi Quality of leucoreduced red blood cell concentrates: 5 years of follow-up in France
    A Chabanel
    Etablissement Français du Sang, Paris, France
    Vox Sang 94:41-7. 2008
    ..Since 1998, prestorage leucoreduction of all cellular blood components has been made mandatory in France. The French blood service needed to follow the data on the quality of the blood components prepared by blood centres...
  69. ncbi A case-control study of risk factors for hepatitis C infection in patients with unexplained routes of infection
    M Karmochkine
    , , Paris, France
    J Viral Hepat 13:775-82. 2006
    ....
  70. ncbi Factors of weight loss in patients with HIV and chronic diarrhea
    L Beaugerie
    Department of Gastroenterology and Nutrition, Hopital Rothschild, Paris, France
    J Acquir Immune Defic Syndr Hum Retrovirol 19:34-9. 1998
    ..These results suggest that, in patients with HIV and chronic diarrhea, the degree of wasting is significantly related to the levels of dietary intake and the clinical severity of diarrhea, but not to the extent of nutrient malabsorption...
  71. ncbi Early virologic failure in HIV-coinfected hepatitis C patients treated with the peginterferon-ribavirin combination: does abacavir play a role?
    Firouzé Bani-Sadr
    J Acquir Immune Defic Syndr 45:123-5. 2007
  72. ncbi Risk factors for bacterial infections in HIV/hepatitis C virus-coinfected patients treated with interferon plus ribavirin
    Firouzé Bani-Sadr
    AIDS 22:1385-7. 2008
  73. ncbi Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: analysis of risk factors
    Firouzé Bani-Sadr
    Groupe Hospitalier Universitaire Est, Universite Paris 6, INSERM U707, France
    Clin Infect Dis 46:768-74. 2008
    ..We determined the prevalence and determinants of worsening fibrosis in patients coinfected with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) who were receiving anti-HCV therapy...
  74. ncbi Risk factors for symptomatic mitochondrial toxicity in HIV/hepatitis C virus-coinfected patients during interferon plus ribavirin-based therapy
    Firouzé Bani-Sadr
    Groupe Hospitalier Universitaire Est, Universite Paris 6, INSERM U444, France
    J Acquir Immune Defic Syndr 40:47-52. 2005
    ..To evaluate the incidence, clinical features, and risk factors for symptomatic mitochondrial toxicity in HIV/hepatitis C virus (HCV)-coinfected patients receiving anti-HCV therapy...
  75. ncbi The cost-effectiveness of influenza vaccination for people aged 50 to 64 years: an international model
    Samuel Aballea
    i3 Innovus, Uxbridge, UK
    Value Health 10:98-116. 2007
    ..To help policymakers consider whether such a policy should be adopted more widely, we conducted an economic evaluation of lowering the age limit for routine influenza vaccination to 50 years in Brazil, France, Germany, and Italy...
  76. ncbi Epidemiology, diagnosis and treatment of chronic hepatitis B in HIV-infected patients (EPIB 2005 STUDY)
    Lionel Piroth
    Service de Maladies Infectieuses et Tropicales, CHU Dijon, 10 boulevard du Maréchal de Lattre de Tassigny, 21079 Dijon Cedex, France
    AIDS 21:1323-31. 2007
    ..To describe the characteristics of hepatitis B (HBV) infection in HIV-infected patients and the impact of anti-HBV treatments...
  77. ncbi Rapid and early virological response to chronic hepatitis C treatment with IFN alpha2b or PEG-IFN alpha2b plus ribavirin in HIV/HCV co-infected patients
    Christopher Payan
    Départment de Microbiologie EA3882, CHU Hôpital Morvan, Brest, France
    Gut 56:1111-6. 2007
    ....
  78. ncbi Expected increase in hepatitis C-related mortality in Egypt due to pre-2000 infections
    Sylvie Deuffic-Burban
    CRESGE LABORES, CNRS URA 362, 1 rue Norbert Ségard, BP 109, 59016 Lille, France
    J Hepatol 44:455-61. 2006
    ..Estimating the future burden of HCV in Egypt is important to support health policies to combat the epidemic...
  79. ncbi Risk factors for grade 3 or 4 gamma-glutamyl transferase elevation in HIV/hepatitis C virus-coinfected patients
    Firouzé Bani-Sadr
    AIDS 22:1234-6. 2008
  80. ncbi Heterosubtypic immunity to influenza: right hypothesis, wrong comparison
    Fabrice Carrat
    J Infect Dis 193:1613; author reply 1613-4. 2006
  81. ncbi Viral pneumonia and respiratory sepsis: association, causation, or it depends?
    Jean Jacques Parienti
    Crit Care Med 35:639-40. 2007